Follow the people · Insider

GC

Gabriele M. Cerrone

Insider · Director and 10% owner · OKYO

Gabriele M. Cerrone files insider transactions with the SEC as an executive chairman of OKYO Pharma (OKYO). We hold 4 disclosed purchases and sales filed since 27 April 2022, 4 of them in the last 90 days.

  • Files forOKYO
  • Disclosed buys and sells4 in all, 4 in the last 90 days
  • Last disclosure7 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 17 May 202221 July 2026Executive Chairman · OKYO Pharma (OKYO)11 Form 4 lines · source: SEC Form 4
  • Filed 12 June 202621 July 2026Director and 10% owner · Tiziana Life Sciences (TLSA)4 Form 4 lines · source: SEC Form 4
  • Filed 25 April 202213 June 2025Director and 10% owner · Accustem Sciences (ACUT)17 Form 4 lines · source: SEC Form 4

Everything they disclosed

32 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.